Desacetylmetipranolol, with the CAS number 57193-14-3, is a chemical compound that belongs to the class of beta-adrenergic antagonists, commonly known as beta-blockers. It is primarily characterized by its ability to block beta-adrenergic receptors, which plays a crucial role in managing cardiovascular conditions such as hypertension and arrhythmias. The compound is a derivative of metipranolol, featuring a desacetylated structure that influences its pharmacological properties. Desacetylmetipranolol is typically administered in a pharmaceutical context, and its mechanism of action involves reducing heart rate and myocardial contractility, thereby decreasing cardiac workload and oxygen demand. In addition to its cardiovascular applications, beta-blockers like desacetylmetipranolol may also be utilized in treating conditions such as glaucoma due to their ability to reduce intraocular pressure. The compound's solubility, stability, and bioavailability are important factors that influence its therapeutic efficacy and safety profile. As with all medications, potential side effects and contraindications should be considered when evaluating its use in clinical practice.

Desacetylmetipranolol

57193-14-3: Desacetylmetipranolol, with the CAS number 57193-14-3, is a chemical compound that belongs to the class of beta-adrenergic antagonists, commonly known as beta-blockers. It is primarily characterized by its ability to block beta-adrenergic receptors, which plays a crucial role in managing cardiovascular conditions such as hypertension and arrhythmias. The compound is a derivative of metipranolol, featuring a desacetylated structure that influences its pharmacological properties. Desacetylmetipranolol is typically administered in a pharmaceutical context, and its mechanism of action involves reducing heart rate and myocardial contractility, thereby decreasing cardiac workload and oxygen demand. In addition to its cardiovascular applications, beta-blockers like desacetylmetipranolol may also be utilized in treating conditions such as glaucoma due to their ability to reduce intraocular pressure. The compound's solubility, stability, and bioavailability are important factors that influence its therapeutic efficacy and safety profile. As with all medications, potential side effects and contraindications should be considered when evaluating its use in clinical practice.

Deacetyltrimepranol also known as Desacetylmetipranolol, is the active metabolite of metipranolol.

CAS 57193-14-3

Desacetylmetipranolol

Deacetyltrimepranol

Ref: TM-T31256

Desacetylmetipranolol

Ref: 47-504